Navigation Links
Danaher CEO Comments on Outlook
Date:12/11/2008

WASHINGTON, Dec. 11 /PRNewswire-FirstCall/ -- Danaher Corporation (NYSE: DHR) commented today on the performance outlook of the company for 2009. President and Chief Executive Officer H. Lawrence Culp, Jr. communicated the company expects 2009 earnings per share to be in the range of $3.70 to $4.10.

Mr. Culp stated, "We have taken significant steps to prepare our businesses for what we believe will be a difficult year ahead. However, despite the current economic backdrop, we believe we are well positioned for 2009."

Danaher Corporation is a leading manufacturer of Professional Instrumentation, Medical Technologies, Industrial Technologies, and Tools and Components (www.danaher.com).

Statements in this release that are not strictly historical, including statements regarding the range of earnings per share expectations for 2009, the Company's positioning for 2009 and any other statements regarding events or developments that we believe or anticipate will or may occur in the future, may be "forward-looking" statements. There are a number of important factors that could cause actual events to differ materially from those suggested or indicated by such forward-looking statements. These factors include, among other things, the current economic recession and the upheaval in the credit markets and financial services industry, competition, our ability to develop and successfully market new products and technologies, our ability to expand our business in new markets, our ability to identify, consummate and integrate appropriate acquisitions, litigation and other contingent liabilities including intellectual property and environmental matters, our compliance with applicable laws and regulations and changes in applicable laws and regulations, tax audits and changes in our tax rate, currency exchange rates, commodity costs and surcharges, our relationships with and the performance of our channel partners, our ability to achieve projected efficiencies, cost reductions, sales growth and earnings, economic and other conditions in the end-markets we sell into, and general domestic and international economic conditions. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in our SEC filings, including our 2007 Annual Report on Form 10-K and Third Quarter 2008 Quarterly Report on Form 10-Q. These forward-looking statements speak only as of the date of this release and the Company does not intend to update any forward-looking statement.


'/>"/>
SOURCE Danaher Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Danaher to Present at Goldman Sachs Global Industrials Conference
2. Danaher Corporation Schedules First Quarter Conference Call
3. Danaher to Present at Citigroup Global Industrial Manufacturing Conference
4. Danaher Closes Subsequent Offering Period for Tektronix; Acquires Over 90% of TEK Shares
5. American College of Surgeons Comments on Institute of Medicine Report on Resident Duty Hours
6. Assurant Comments on A.M. Best Ratings Statement; Ratings Continue to Reflect Assurants Solid Financial Position
7. Consumer Watchdog Comments on Health Insurers Self-Serving Support of Individual Mandate
8. The Senior Citizens Leagues Comments on U.S. Supreme Court Case Wyeth v. Levine
9. Seyfarth Shaw Partner Camille A. Olson, Senate Witness for ADA Amendments Act, Comments on President's Signing of Bill into Law
10. Conscience Protections Essential to Healthcare System, Americans United for Life Argues in Comments Filed with HHS
11. Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... Next week ... will be repealed by Congressional political games that circumvent health needs of over 30 ... Rally” capture the human anxieties and needs government public servants were suppose to prioritize. ...
(Date:1/19/2017)... ... 19, 2017 , ... This month, the CEO and Clinical Director of Sober ... rehab center in Delray Beach, Florida has been changed from Sober Living Outpatient to ... Philip Seymour Hoffman and Chris Farley are dying from heroin overdoses, but thousands of ...
(Date:1/19/2017)... ... January 19, 2017 , ... Remote Medical Technologies (RMT), ... transportable capabilities with their iMedHD2™ Portable Teleultrasound System. Compatible with ... that delivers HD, dynamic, streaming ultrasound images and video to one or more ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... Gattefossé, the leader in innovative excipients and drug delivery solutions to health industries ...
(Date:1/19/2017)... ... January 19, 2017 , ... Bio-Optronics Inc. is proud to ... workflow designed to seamlessly integrate and streamline the way researchers prepare and conduct ... maximizing usability and improving efficiency significantly for users – a first in the ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017  Sensus Healthcare, Inc. (NASDAQ: ... the treatment of non-melanoma skin cancers and other ... therapy, today announced that it will report its ... on Thursday, February 2, 2017 after the market close. ... call with the investment community on Thursday, February 2, ...
(Date:1/19/2017)... January 19, 2017 New ... to Address Motor Symptoms and Motor Complications in ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) C ... European Neurological Review,2016;11(Suppl. 2): 2-15, http://www.touchneurology.com/articles/safinamide-new-therapeutic-option-address-motor-symptoms-and-motor-complications-mid-late ...
(Date:1/19/2017)... 2017 The Global Therapy Partnering Terms and ... partnering deals and agreements entered into by the world,s ... - Top deals by value - Deals listed by ... The report provides understanding and access to the ... leading healthcare companies. The report provides an analysis ...
Breaking Medicine Technology: